Skip to main content
. 2019 May 20;101(1):164–179. doi: 10.4269/ajtmh.18-0534

Figure 1.

Figure 1.

Reverse cumulative distribution functions of baseline and month 13 neutralizing antibodies by serotype. (A) Month 13 50% plaque reduction neutralization test (PRNT50) titers in CYD-TDV vaccine recipients receiving all three vaccinations by age cohort in CYD22, CYD47, and CYD14 + CYD15. (B) Baseline PRNT50 titers in the CYD-TDV vaccine and placebo recipients pooled. This figure appears in color at www.ajtmh.org.